Authors: | Fuchsjaeger, M.; Shukla-Dave, A.; Akin, O.; Barentsz, J.; Hricak, H. |
Article Title: | Prostate cancer imaging |
Abstract: | As prostate cancer is a biologically heterogeneous disease for which a variety of treatment options are available, the major objective of prostate cancer imaging is to achieve more precise disease characterization. Magnetic resonance imaging (MRI) may enhance the staging of prostate cancer compared with clinical evaluation, transrectal ultrasound, or computed tomography (CT), and allows concurrent evaluation of prostatic, periprostatic, and pelvic anatomy. In clinical practice, the fusion of MRI or dynamic contrast-enhanced MRI (DCE-MRI) with MR spectroscopic imaging (MRSI) is improving the evaluation of cancer location, size, and extent, while providing an indication of tumor aggressiveness. Pretreatment knowledge of these prognostic variables is essential for achieving minimally invasive, patient-specific therapy. © 2008 Informa UK Ltd. (Informa Healthcare, Taylor & Francis AS). |
Keywords: | review; cancer staging; nuclear magnetic resonance imaging; positron emission tomography; methodology; magnetic resonance imaging; neoplasm staging; neoplasms; computer assisted tomography; tomography, x-ray computed; pathology; oncology; prostatic neoplasms; prostate; computerized tomography; medical imaging; prostate tumor; positron-emission tomography; scintiscanning; magnetic resonance spectroscopy; nuclear magnetic resonance spectroscopy; radiography; diffusion weighted imaging; diffusion magnetic resonance imaging; ct; mr imaging; prognostic variables; mr spectroscopy; mr diffusion/perfusion; neoplasms, primary; mr diffusion |
Journal Title: | Acta Radiologica |
Volume: | 49 |
Issue: | 1 |
ISSN: | 0284-1851 |
Publisher: | Sage Publications Ltd. |
Date Published: | 2008-02-01 |
Start Page: | 107 |
End Page: | 120 |
Language: | English |
DOI: | 10.1080/02841850701545821 |
PUBMED: | 18210320 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | --- - "Cited By (since 1996): 42" - "Export Date: 17 November 2011" - "CODEN: ACRAE" - "Source: Scopus" |